FIELD: pharmacology.
SUBSTANCE: invention relates to compounds of the formula
,
as well as to pharmaceutical compositions based thereon for use in the treatment of a disease or condition mediated by SNK1.
EFFECT: new compounds are obtained that inhibit the kinase function of kinase 1 of the control point.
37 cl, 2 dwg
| Title | Year | Author | Number |
|---|---|---|---|
| 5-[[4-[[MORPHOLIN-2-YL]METHYLAMINO]-5-(TRIFLUOROMETHYL)-2-PYRIDYL]AMINO]PYRAZINE-2-CARBONITRILE, THERAPEUTIC USES THEREOF | 2013 |
|
RU2659786C2 |
| MACROHETEROCYCLIC NUCLEOSIDE DERIVATIVES AND ANALOGUES THEREOF, PRODUCTION AND USE | 2017 |
|
RU2731385C1 |
| QUINAZOLINE INHIBITORS OF ACTIVATING MUTANT FORMS OF EPIDERMAL GROWTH FACTOR RECEPTOR | 2014 |
|
RU2656597C2 |
| EGFR INHIBITOR COMPOUNDS | 2017 |
|
RU2751341C2 |
| 2-(AZAINDOL-2-YL)BENZIMIDAZOLE DERIVATIVES AS PAD4 INHIBITORS | 2012 |
|
RU2611010C2 |
| DERIVATIVES OF 6-AMINO QUINAZOLINE OR 3-CYANOQUINOLINE, METHODS OF THEIR PRODUCTION AND THEIR APPLICATION AS INHIBITORS OF RECEPTOR TYROZINE KINASES EGFR OR HER-2 | 2010 |
|
RU2536102C2 |
| PHTHALAZINE KETONE DERIVATIVE, METHOD OF OBTAINING THEREOF AND PHARMACEUTICAL APPLICATION | 2011 |
|
RU2564527C2 |
| SELECTIVE KINASE JAK1 INHIBITOR | 2020 |
|
RU2818002C2 |
| NOVEL COMPOUNDS AND COMPOSITIONS FOR INHIBITION OF FASN | 2014 |
|
RU2686323C2 |
| NEW DERIVATIVES OF 5, 7-DISUBSTITUTED [1, 3] THIAZOLO[4, 5-D] PYRIMIDINE-2(3H)-ONE | 2006 |
|
RU2411245C9 |
